Dongsung Pharm (002210) — Capital Reinvestment Ratio
Dongsung Pharm (002210) has a Capital Reinvestment Ratio of 0.54x as of December 2024, meaning it reinvests 1% of its operating cash flow (₩3.01 Billion) in capital expenditures (₩1.62 Billion). Check 002210 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Dongsung Pharm Capital Reinvestment Ratio (2010–2020)
This chart tracks Dongsung Pharm's Capital Reinvestment Ratio across 4 annual periods. For the full cash flow conversion analysis, see 002210 cash generation efficiency.
Annual Capital Reinvestment Ratio for Dongsung Pharm (2010–2020)
Year-by-year Capital Reinvestment Ratio for Dongsung Pharm from 2010 to 2020. See Dongsung Pharm free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 1.38x | ₩5.01 Billion | ₩6.92 Billion | ▼ -9.5% |
| 2018 | 1.53x | ₩1.39 Billion | ₩2.13 Billion | ▼ -8.6% |
| 2017 | 1.67x | ₩1.80 Billion | ₩3.00 Billion | ▲ +626.3% |
| 2010 | 0.23x | ₩3.68 Billion | ₩847.33 Million | — |